Merck KGaA (OTCMKTS:MKGAF – Get Free Report)’s stock price fell 3.2% on Wednesday . The company traded as low as $126.09 and last traded at $126.09. 126 shares were traded during trading, a decline of 89% from the average session volume of 1,116 shares. The stock had previously closed at $130.20.
Merck KGaA Stock Performance
The company has a quick ratio of 0.84, a current ratio of 1.31 and a debt-to-equity ratio of 0.27. The company has a market cap of $16.72 billion, a PE ratio of 19.75 and a beta of 0.96. The stock’s 50 day simple moving average is $134.65 and its two-hundred day simple moving average is $140.97.
About Merck KGaA
Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.
Recommended Stories
- Five stocks we like better than Merck KGaA
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Congress’s May Stock Trades: What They Know That You Don’t
- What is a Low P/E Ratio and What Does it Tell Investors?
- McDonald’s Is Down, But Long-Term Investors Can Still Take a Bite
- Canadian Penny Stocks: Can They Make You Rich?
- Rivian vs. Lucid: Who’s Best Positioned to Steal Tesla’s Thunder?
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
